As an adult medical oncologist, Daniel Catenacci, MD, specializes in the treatment of gastrointestinal malignancies with particular focus on gastroesophageal cancers. Dr. Catenacci works with a multi-disciplinary team of surgical oncologists, radiation oncologists, and medical oncologists to provide the most optimal care possible for cancer patients.
An active basic and clinical researcher, Dr. Catenacci is involved in bench-to-bedside translational research for gastroesophageal cancer. He conducts basic investigations on normal and cancer cell signaling with the ultimate goal of developing new inhibitory drugs for the treatment of gastroesophageal cancer and other digestive malignancies. Additionally, Dr. Catenacci conducts clinical trials, using novel clinical trial designs, based on laboratory findings and discoveries.